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Summary 
To determine the extent and nature of genetic varia- 
tion present in independent isolates of HTLV-IIIILAV, 
the nucleotlde sequences of the entire envelope gene 
and parts of gag and pal were determined for two AIDS 
viruses. The results indicated that variation through- 
out the viral genome is extensive and that the enve- 
lope gene in particular is most highly variable. With- 
in the envelope, changes were most prevalent within 
the extracellular region where clustered nucleotlde 
substitutions and deletlonslinsertlons were evident. 
Based on predicted secondary protein structure and 
hydrophillcity, these hypervariable reglons represent 
potential antigenic sites. In contrast to the hypervaria- 
ble regions, other sequences in the extracellular enve- 
lope and the overall envelope structurrc (lncludlkg 18 
of 18 cysteine residues), as well as most of the trans- 
membrane region, were highly conserved. 
Introduction 
The extreme morbidity, high mortality, and epidemic pro- 
portions of the acquired immune deficiency syndrome 
(AIDS) have led to intense scientific efforts to elucidate the 
disease’s pathogenesis and develop effective preventive 
and treatment measures. Fundamental to this effort was 
the identification and characterization of HTLV-IIIILAV as 
the causative agent of AIDS (Barre-Sinoussi et al., 1983; 
Popovic et al., 1984; Gallo et al., 1984; Schupbach et al., 
1984; Sarngadharan et al., 1984) and the subsequent 
molecular characterization of the viral genome (Hahn et 
al., 1984; Shaw et al., 1984; Alizon et al., 1984; Luciw et 
al., 1984; Ratner et al., 1985a; Wain-Hobson et al., 1985; 
Sanchez-Pescador et al., 1985; Muesing et al., 1985). 
A troublesome finding, given its potential clinical impli- 
cations, made early in the genetic analysis of HTLV-III/LAV 
was that independent virus isolates were heterogeneous 
in their genomic restriction enzyme cleavage patterns 
(Shaw et al., 1984,1985; Wong-Staal et al., 1985). This ob- 
servation was extended by electron microscopic hetero- 
duplex studies (Hahn et al., 1985), DNA sequencing 
(Ratner et al., 1985a; Wain-Hobson et al., 1985; Sanchez- 
Pescador et al., 1985; Muesing et al., 1985), and addi- 
tional restriction enzyme mapping (Benn et al., 1985), all 
of which indicated that substantial genomic variation is 
present in different AIDS virus isolates and that the enve- 
lope might be particularly variable compared to other viral 
genes (Ratner et al., 1985b; Rabson and Martin, 1985). 
From these studies, however, it was impossible to esti- 
mate accurately the extent and nature of genomic hetero- 
geneity present among independent AIDS virus isolates 
because restriction mapping and heteroduplexing lacked 
sufficient sensitivity and because sequence comparisons 
were performed on only three virus isolates, two of which 
were relatively closely related to each other. 
Because of these limitations, and because a more com- 
plete understanding of genomic heterogeneity would un- 
doubtedly be critical to elucidating the virus’s evolutionary 
history and pathobiology, we undertook a study of genetic 
variation in five independent HTLV-IIIILAV isolates. Here 
we present an analysis of the nucleotide and deduced 
amino acid sequences of the complete envelope genes 
and parts of gag and polfor HTLV-IIIILAV isolates obtained 
from two Haitian patients with AIDS and compare these 
to the published sequences of HTLV-III (Ratner et al., 
1985a), LAV (Wain-Hobson et al., 1985), and ARV (San- 
chez-Pescador et al., 1985). The results of these studies 
provide considerable new insight into the extent and na- 
ture of genetic variation present in field isolates of HTLV- 
III/LAV, and provide important information regarding the 
rate and mechanisms by which these changes occur in 
vivo. 
Results 
Nucleotide Sequence Determination and Analysis 
Isolates of HTLV-IIIILAV were ,obtained from peripheral 
blood mononuclear cells. Isolate RF was obtained in 1983 
as previously described (Popovic et al., 1984) and was 
propagated in an immortalized T cell line from which it 
was molecularly cloned (Hahn et al., 1985). isolate WMJ-1 
was similarly transmitted from the peripheral blood 
mononuclear cells of a Haitian infant with AIDS to an im- 
mortalized T cell line (Hahn et al., 1988). Molecular clones 
of both RF (designated HAT-3) and WMJ-1 were prepared 
as described in Experimental Procedures. 
The genome of HTLV-IIIILAV consists of long terminal 
repeat (LTR) elements; gag, po/, and env genes; two 
regions of unknown significance designated sor for short 
open reading frame and 3’ orf for 3’ open reading frame; 
and a third region previously thought to be noncoding 
(NCR) but now known to encode the first exon of the HTLV- 
Table 1. Sequence Comparison of Five Independent AIDS Virus Isolates 
Nucleotide Differences Compared to BH-IO (number of nucleotide changes/number of nucleotides sequenced) 
Leader 
Sequence envelope 
and 
Primer Extra- Trans- 
Binding NCR Signal cellular membrane 
Clones LTR Site gag Pal sor W Peptide portion portion 3’ orl Total 
HAT-3 49634 13/152 7711285 4611246 171484 481584 28/111 202/l 443 87/l 035 891648 845i7489 
7% 8.5% 5.9% 3.7% 3.8% 8.2% 23.4% 14.0% 8.4% 10.8% 8.8% 
ARV-2 301834 141152 8611538 13413045 31/809 491584 28/111 16411443 88/l 035 521848 582l9213 
4.7% 9.2% 5.8% 4.4% 5.1% 8.4% 23.4% 11.4% 8.3% 8.0% 8.3% 
LAV-la 101634 71152 46i1536 5913045 2/809 11 I584 2/111 32l1443 g/1035 131648 14419213 
1.8% 4.8% 3.0% 1.9% 0.3% 1.9% 1.8% 2.2% 0.9% 2.0% 1.5% 
WMJ-1 nd nd 38/1182a nd nd nd 27/l 11 17711443 82/1035 nd nd 
3.3% 24.3% 12.3% 8.0% 
Amino Acid Differences Compared to BH-10 (number of amino acid changes/number of amino acids sequenced) 
HAT-3 - - 28i428 221415 101154 - 11137 103/481 45/345 371216 256/2039 
- 8.5% 5.3% 8.4% - 29.7% 21.4% 13.00/, 17% 12.5% 
ARV-2 - - 32l512 51/1015 20/203 - 13137 82l481 421345 291216 239/2593 
- 6.3% 5.0% 9.8% - 35.1% 17.0% 12.2% 12.2% 9.2% 
LAV-la - - 161512 2111015 01203 - 2137 141481 51345 81218 5812593 
- 3.1% 2.1% 0% - 5.4% 2.9% 1.4% 3.7% 2.2% 
WMJ-1 - - 12Ki87a nd nd - 13137 90/481 291345 nd nd 
3.1% - 36.1% 18.7% 8.4% 
Nucleotide and amino acid sequence comparisons of five independent AIDS virus isolates using the BH-10 clone of HTLV-lllb as a reference (Rat- 
ner et al., 1965a). Deletions and insertions, as illustrated in Figures 1 and 2, are included in the analysis. Data for ARV-2 and LAV-la have been 
reported elsewhere (Sanchez-Pescador et al., 1985; Wain-Hobson 81 al., 1985). Data for HAT-3 and WMJ-1 are from the present study. As dis- 
cussed in the text and shown here, the entire LTR, NCFUtet, envelope, and 3’orf. as well as most of gag, pal, and sor, were sequenced for HAT-3. 
For WMJ-1, the entire envelope gene was sequenced. 
B For WMJ-2, a highly related viral clone from this same patient, the complete sequence of the gag p24 and pi5 is shown (Hahn et al., 1988). 
IlllLAV transactivator (tat III) gene (Ratner et al., 1985a; 
Wain-Hobson et al.,1985; Sanchez-Pescador et al., 1985; 
Rosen et al., 1988). For HAT-3, we determined the nucleo- 
tide sequence of the entire LTR, env, 3’ orf, and NCR (tat) 
regions as well as 84% of gag, 41% of pal, and 76% of 
sor. For WMJ-1, only the env gene was sequenced, but for 
two other WMJ clones that were closely related to WMJ-1, 
both env and gag (~15 and p24 regions) were sequenced 
(Hahn et al., 1986). From this analysis, and from restriction 
enzyme mapping and heteroduplexing, we confirmed that 
the overall genomic organization of HAT-3 and WMJ-1 is 
the same as that described previously for HTLV-III, LAV, 
and ARV. 
Table 1 compares the nucleotide and deduced amino 
acid sequence8 of HAT-3, WMJ-1, LAV-la, and ARV-2 to 
the original HTLV-lllb clone, BH-10. These data dem- 
onstrate the existence of a broad spectrum of diversity 
among the AIDS retroviruses: Overall, BH-10 differed from 
HAT-3 in 8.6% of nucleotides (12.5% amino acids), from 
ARV-2 in 6.3% of nucleotides (9.2% amino acidsj, and 
from LAV-la in 1.5% of nucleotides (2.2% amino acids). 
HAT3 and ARV-2 differed from each other over the lengths 
of their sequenced genomes by 9.3% of nucleotides 
(14.2% amino acids). A similar spectrum of diversity 
among independent HTLV-III/LAV isolates has been re- 
ported on the basis of restriction enzyme mapping (Wong- 
Staal et al., 1985; Benn et al., 1985). 
The distribution of sequence differences was not uni- 
form throughout the viral genomes. Instead, when diver- 
gent genomes were compared, changes were found to be 
considerably more prevalent in the envelope and 3’ orf 
than in other genes (Table 1). In the envelope gene in par- 
ticular, BH-10 differed from HAT-3 in 12.9% of nucleotides 
(19% amino acids), from ARV-2 in 9.8% of nucleotides 
(15.7% amino acids), and from WMJ-1 in 9.3% of nucleo- 
tides (14.0% amino acids). In the same region, HAT-3 
differed from ARV-2 in 14.7% of nucleotides (18.4% amino 
acids) and from WMJ-1 in 11.3% of nucleotides (16.5% 
amino acids). ARV-2 and WMJ-1 differed from each other 
in this region by 10.0% of nucleotides (16.2% amino 
acids). Within the envelope gene, the signal peptide and 
extracellular portion were the regions that were most 
highly divergent. For example, the extracellular envelope 
domains of HAT-3, WMJ-1, and ARV-2 differed from that 
of BH-10 in 21.4%, 18.7%, and 17.0% of amino acids, 
respectively. The two Haitian isolates, HAT-3 and WMJ-1, 
differed from each other in this region by 21.6% amino 
acids and from ARV-2 by 20.2% and 20.80/o, respectively. 
The most conserved areas in the genomes of HAT-3, 
LAV-la, BH-10, and ARV-2 were the gag and pol genes, 
which differed among the viruses in less than 6% of 
nucleotides and less than 7% of amino acids. In these 
regions, nucleotide sequence changes were almost exclu- 
sively due to point mutations in contrast to env where 
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clustered nucleotide changes involving in-frame defe- 
tions, insertions, and/or duplications were common. For 
example, compared to BH-10, there were 48 bp of inser- 
tions and 21 bp of deletions in the extracellular envelope 
of HAT-3 as compared to only 6 bp of insertions and dele- 
tions in all of its analyzed gag, pal, and sor sequences. 
Similarly, there were 33 bp of insertions and 36 bp of dele- 
tions in the extracellular envelope of ARV-2 (compared to 
BH-10) but only a 6 bp insertion and no deletions in all of 
its gag, pal, and sor. Even in LAV-la, which is more closely 
related to BH-10 than are the other sequenced viruses, 
there was a 15 bp insertion (duplication) in the exterior 
envelope gene but no insertions or deletions in gag, pal, 
or sor. Not included in this comparative analysis is a single 
direct repeat at the gaglpol junction of BH-10 that is not 
present in any of the other isolates. 
Another difference in the types of mutations present in 
the env gene compared to the gag gene of these viruses 
was in the proportion of silent third base pair changes. Ex- 
cluding deletions and insertions, compared to BH-10 the 
mutations in the external env genes of ARV-2, HAT-9 and 
WMJ (clone WMJ-2 from patient WMJ; see Hahn et al., 
1986) were in the third position of the codon in 36%, 370/6, 
and 34% of instances leading to 32%, 25% and 42% 
amino acid changes, respectively. Conversely, in the gag 
genes of these same viruses, 63%, 560/o, and 66% of 
nucleotide changes were in the third place of the codon 
leading to lo%, 3.5% and 0% amino acid changes, 
respectively. Thus more than half of the single nucleotide 
changes in envoccurred in the first or second codon posi- 
tion, and even for third position changes, many of these 
led to amino acid changes. Conversely, only a minority of 
first or second codon position changes occurred in gag, 
and in this gene the third position changes were almost 
uniformly silent. These findings are consistent with two in- 
terpretations; first, that structure-function relationships 
lead to stronger conservation of amino acid sequence in 
gag than in env, and, second, that non-silent nucleotide 
changes in env may actually be under positive selection 
pressure. Whether or not the latter interpretation is correct 
must await a much more complete understanding of the 
host immunologic response to HTLV-IIIILAV. 
Alignment and Comparison of Envelope Sequences 
An alignment of the envelope nucleotide and amino acid 
sequences of HAT-3, WMJ-1, BH-10, LAV-la, and ARV-2 is 
shown in Figures 1 and 2. A methionine codon at position 
8 of the BH-10 envelope open reading frame most likely 
marks the beginning of the gene, with a hydrophobic re- 
gion between position 17 and 37 representing the potential 
leader sequence. It is known from the amino acid se- 
quence of the mature envelope glycoprotein that this 
leader sequence, or signal peptide, is cleaved from the 
envelope precursor protein during envelope maturation 
(Allen et al., 1985). The ensuing peptide sequence from 
position 38 to 518 (BH-10 sequence) is slightly hydrophilic 
and contains numerous potential N-linked glycosylation 
sites, ranging from 22 in WMJ-1 to 29 in HAT-3. This region 
corresponds to the major exterior envelope glycoprotein 
(gpl20). A characteristic arginine-rich hydrophobic stretch 
marks the cleavage site for the processing of the envelope 
precursor gp160 into the exterior gpl20 and membrane- 
bound gp41 (Allen et al., 1985; DiMarzo-Veronese et al., 
1965). The latter protein includes an apparent hydropho- 
bic membrane-spanning segment, a hydrophilic anchor 
sequence, and an additional carboxy-terminal stretch of 
150 residues whose function is presently unknown. 
A striking feature of the five envelope sequences was 
the conservation of cysteine residues (Figure 2). Within 
the extracellular envelope, each of the 18 cysteine res- 
idues was conserved in all five viruses. Within the trans- 
membrane protein, all but one cysteine residue in its ex- 
treme carboxy-terminus was conserved. This finding 
argues for a highly conserved “macrostructure” of differ- 
ent HTLV-IIIILAV envelope glycoproteins. Despite this 
overall conservative structure, numerous amino acid 
changes were evident throughout the envelope glycopro- 
tein. In the transmembrane region these were generally 
the result of isolated nucleotide point mutations leading to 
single amino acid substitutions. In the extracellular re- 
gion, changes in amino acid sequence resulted from both 
nucleotide point mutations and in-frame deletions, inser- 
tions, or duplications of blocks of nucleotides. The result- 
ing amino acid alterations appeared as clustered muta- 
tions interspersed with polypeptide segments that were 
highly conserved. The regions of highest variability (dark 
shading in Figure 2) and highest conservation (light shad- 
ing in Figure 2) were identified both by visual inspection 
and by objective determination of relative variation using 
computer analysis (Figure 3). 
Predicted Secondary Structure 
Since the extracellular region of the HTLV-III/LAV enve- 
lope glycoprotein constitutes a major target of the host im- 
munologic response (Barin et al., 1985a), we examined 
this region for predicted antigenic epitopes using a com- 
puter program that predicts the secondary structure of 
proteins superimposed with values for hydrophilicity 
(Chou and Fasman, 1974; Hopp and Woods, 1981). Such 
an analysis of other proteins, including viral envelopes, 
has shown that antigenic epitopes are often associated 
with hydrophilic protein domains containing 6 turns 
(Atassi, 1978; Cohen et al., 1964; Westhoff et al., 1984; 
Eisenberg et al., 1985; Gunn et al., 1985; Pellett et al., 
1985). This analysis demonstrated that the exterior enve- 
lope proteins of the five AIDS retroviruses each contain a 
number of sites that meet criteria for likely antigenic epi- 
topes and that these regions generally coincide with the 
variable regions identified independently by amino acid 
sequence comparisons. Figure 4 illustrates the substan- 
tial differences in predicted secondary protein structure 
for the first variable region of the external envelope gene 
product for the five viruses. In this region, there were 7 6 
turns in HAT-9 0 6 turns in WMJ-1, 8 6 turns in BH-10, 11 
p turns in LAV-la, and 5 p turns in ARV-2. The five enve- 
lope sequences also differed in this region in their 
degrees of hydrophilicity and in the number and location 
of potential N-linked glycosylation sites (Figures 2 and 4). 
In each of the other variable regions substantial differ- 
ences existed similarly in predicted hydrophilicity, second- 
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Figure 2. Amino Acid Sequences of the Entire Envelope Genes of Five Independent AIDS Vi- 
rus Isolates 
Sequence information for BH-IO (HTLV-lllb), ARV-2. and LAV-la wasobtained from GENBANK 
and information for WMJ-1 and HAT3 from the present study. Alignment of the sequences was 
performed pair-wise with the assistance of PRTALN (Wilbur and Lipman, 1993). Numbering 
of amino acids is from the first amino acid of BH-10 and regions corresponding to the signal 
peptide, extracellular envelope glycoprotein (gp120), and transmembrane glycoprotein (gp41) 
are shown. Dashes indicate amino acid identity with BH-t0 and spaces indicate the absence 
of that amino acid. Arrows denote cysteine residues and solid and open circles denote con- 
served and nonconserved sites of potential N-linked glycosylation, respectively. Darkly 
shaded regions within the extracellular envelope glycoprotein correspond to regions of hyper- 
variability as determined by both visual inspection and by computer analysis of variation (see 
Figure 3). Lightly shaded regions correspond to areas that are relatively highly conserved. 
Note that additional regions of intermediate variability are interspersed among highly variable 
and highly conserved areas. 
ary structure, and potential glycosylation sites (S. Modrow, 
unpublished data). 
Interspersed with the variable regions of the exterior 
envelope protein were other areas that were highly con- 
served among all five isolates analyzed. Most of these 
regions were primarily hydrophobic and contained only 
few or no 6 turns. Accordingly, they are believed to be less 
likely to represent antigenic epitopes. There were, how- 
ever, a number of exceptions. One such exception is a 
conserved stretch of 46 amino acid residues immediately 
adjacent to the processing site of the envelope precursor 
(amino acids 473 through 516 in Figure 2). This area, 
shown also in Figure 4, was very highly conserved among 
all five viruses, contained numerous 6 turns, and was 
hydrophilic. Thus this conserved region of the exterior 
envelope glycoprotein would be expected to be both anti- 
genie and cross-reactive among different viral strains. It 
has recently been shown that a synthetic peptide gener- 
ated from a portion of this region does in fact detect natu- 
rally occurring antibodies in many patients infected with 
HTLV-IIIILAV and that monoclonal antibodies directed 
against peptides of this region recognize the native gp120 
(T. Palker and B. Haynes, personal communication). 
Discussion 
A growing body of scientific evidence indicates that the 
rate of evolution for RNA viruses in general is much 
rrved and Variable Regions in HTLV-WLAV 
Figure 3. Computer Graphic Illustrating Relative Variation, or Divergence, in the Envelope Genes of Five Independent AIDS Virus Isolates, HTLV-lib 
@H-10), LAV (LAV-la), ARV (ARW2) HTLV-Illnr (HAT-3). and HTLV-lllwu.~ (WMJ-1) 
Relative degrees of variation were calculated as described in Experimental Procedures and plotted from 0 (minimum divergence) to 10 (maximum 
divergence). Beneath the abscissa are single-letter codes for conserved amino acids that were present in five out of five or four out of five of the 
sequences. Numbering of amino acids is based on the envelope sequence as shown on the absicca. The boxed amino acid sequences in line 180 
and line 540 correspond to the variable and conserved regions whose secondary structures are depicted in Figure 4. 
greater than for most prokaryotic or eukaryotic DNA ge- 
nomes (for review, see Holland et al., 1982). From the data 
reported here, it is apparent that substantial heterogeneity 
exists among independent isolates of the AIDS virus. In 
another study (Hahn et al., 1986) we examined serial iso- 
lates of HTLV-IIIILAV from chronically infected individuals 
and showed that the types of nucleotide changes de- 
scribed in this paper for independent virus isolates are 
also present in serial virus isolates from the same patients 
and that these changes occur over a very short period of 
time during the course of viral infection. In fact, we esti- 
mate the rate of genetic change for the HTLV-IIIILAV enve- 
lope gene to be at least toe3 nucleotide substitutions per 
site per year, a mutational rate equal to that of influenza 
A virus and a million times greater than for most eu- 
karyotic genes (Hahn et al., 1986). 
An understanding of the mechanisms by which genetic 
variation occurs in HTLV-III/LAV can be approached by 
comparative analysis of the five sequenced genomes de- 
scribed herein. The finding of frequent point mutations 
throughout the viral genome, and the analogy with other 
RNA viral systems (Zarling and Temin, 1975; Clements et 
al., 1980; C’Rear andTemin, 1982; Shtivelman et al., 1983; 
Darlix and Spahr, 1983; Bruck et al., 1984; Salinovich et 
al., 1986), suggest that mutational events resulting from 
RNA-dependent DNA polymerase (reverse transcriptase) 
misreading coupled with a lack of proofreading enzymes 
contributes in a major way to genetic variation in HTLV- 
IIIILAV In addition to this, the presence of numerous adja- 
cent perfect and imperfect direct repeats within the hyper- 
variable regions of the external envelope gene (see boxed 
nucleotides in Figure 1) suggests that duplications, inser- 
tions, and deletions also contribute to genetic variation in 
HTLV-IIIILAV In this light, it is noteworthy that in some in- 
stances HTLV-IIIILAV sequences appear to have been 
duplicated and then one of the copies changed, the result 
being that novel amino acids are introduced within that re- 
gion. Direct repeats encompassing deletions have been 
observed in other biologic systems, both eukaryotic (Ef- 
stratiadis et al., 1980) and prokaryotic (Farabaugh et al., 
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1978) and in the lac I gene of E. coli such direct repeats 
correspond to hotspots of spontaneous genetic mutation 
(Farabaugh et al., 1978). 
Other potential mechanisms for genomic change in 
HTLV-IIIILAV include recombination between different vi- 
ral DNA molecules or between viral DNA and host DNA. 
Both processes are known to occur in other retroviral sys-  
tems (Coffin, 1979; O ’Rear and Temin, 1982; Dorner et al., 
1985; Bishop and Varmus, 1985). In this study, and in a 
related study in which serial AIDS virus isolates from three 
patients were analyzed by restriction mapping or DNA se- 
quencing (Hahn et al., 1988) evidence for recombination 
between different viral molecules was not apparent. How- 
ever, given the high rate of genetic change in HTLV-IIIILAV 
and the persistence within a given individual of more than 
one predominant viral form (Shaw et al., 1984; Wong-Staal 
et al., 1985; Hahn et al., 1986), genetic recombination be- 
tween different HTLV-IIIILAV molecules is a distinct possi- 
bility. The second process, recombination between viral 
and cellular DNA, appears much less likely. None of the 
AIDS virus isolates studied here contained DNA se- 
quences closely related to normal human DNA as deter- 
mined by Southern blot hybridization (Hahn et al., 1964; 
Luciw et al., 1984; Alizon et al., 1984), and comparison of 
their envelope nucleotide sequences did not reveal any 
large unexplained insertions or rearrangements (see Fig- 
ure 1). Still another potential source for genetic variation 
in HTLV-III/LAV is the formation of stable secondary struc- 
tures (stem-loops) in the viral RNA which in turn could 
lead to localized areas of reverse transcriptase misread- 
ing. This process has been proposed to explain in part 
the variation observed in foot and mouth disease virus 
(Weddell et al., 1965), but for HTLV-IIIILAV we found no 
evidence for such stem-loop structures. In sum, the 
nucleotide sequence data from independent HTLV-IIIILAV 
isolates, along with the analysis of sequential viral isolates 
from individual patients (Hahn et al., 1986) suggest 
strongly that point mutations, in combination with short 
deletions or insertions/duplications perhaps related to 
copy-choice misreading by the viral polymerase, are the 
primary mechanisms by which variation is generated in 
the AIDS virus. 
The finding of genomic variation primarily in the ex- 
tracellular envelope gene in regions having properties 
predictive of antigenicity raises the possibility that host- 
related immunologic pressures may select for variant vi- 
ral strains. For two retroviruses related to HTLV-IIIILAV, 
namely equine infectious anemia virus (EIAV) and visna 
virus, there is evidence that progressive changes in the 
envelope genes do in fact lead to substantial changes in 
envelope antigenicity (Clements et al., 1960; Montelaro et 
al., 1984; Salinovich et al., 1986). These genetic changes 
are localized predominantly within the envelope gene, in 
contrast to gag and pal, and there is evidence that they 
result from immunologic selective pressures exerted by 
the host. For EIAV, there is considerable support for the 
idea that such changes in viral antigenicity are directly 
responsible for the chronic, periodic nature of the disease 
(Salinovich et al., 1986). For visna virus, similar changes 
in envelope antigenicity leading to loss of virus neutraliza- 
tion by host antibodies have been noted (Clements et al., 
1980). However,  the biologic relevance of these findings 
has been questioned by other workers who have dis- 
covered spread of virus in blood and CSF unabated by 
neutralizing antibodies (Petursson et al., 1976), long-term 
persistence of parental viral strains even after the appear- 
ance of variants (Lutley et al., 1983) and lack of antigenic 
variants in some animals even during advanced stages of 
disease (Thormar et al., 1983). Given the complexities of 
chronic retroviral-induced disease (Haase et al., 1977; 
Brahic et al., 1981; Stowring et al., 1985) it is likely that 
intrinsic viral characteristics as well as host-viral immune 
interactions play important roles in clinical outcome. 
For HTLV-IIIILAV, the biologic significance of envelope 
variation has been particularly difficult to ascertain be- 
cause the nature of the host immunologic response to the 
virus has yet to be well characterized. Naturally occurring, 
cross-reactive, neutralizing antibodies specific for HTLV- 
IlllLAV have been identified in individuals infected with 
HTLV-IIIILAV (Robert-Guroff et al., 1985; Weiss et al., 
1985). Furthermore, preliminary data also indicate that 
type-specific anti-HTLV-IIIILAV antibodies are generated 
in vivo and that variants of HTLV-IIIILAV evolve which, de- 
termined by their susceptibility to neutralization by homol- 
ogous sera are antigenically distinct (M. Robert-Guroff 
and W. Parks, personal communication). Whether or not 
such type-specific neutralizing antibodies select for bio- 
logically important antigenic variants of HTLV-IIIILAV dur- 
ing persistent viral infection in man remains to be seen. 
Other mechanisms, unrelated to the immune system, 
could conceivably be involved in the selection of HTLV- 
IlllLAV variants. For example, host-specific and tissue- 
specific properties of the cell membrane receptor for the 
virus could select for alterations in the viral envelope as 
the virus spreads through genetically different individuals 
or through different t issues within a given host (Shaw et 
al., 1985; Ho et al., 1985). Such a mechanism has been 
proposed as a possible explanation for envelope diver- 
gence in foot and mouth disease virus (FMDV), since this 
virus naturally infects many different animal species in- 
Figure 4. Predicted Secondary Structure and Hydrophilicity Patterns of Representative Variable and Conserved Envelope Regions of SH-10, AFtV-2, 
LAV-la, WMJ-1. and HAT-3 
The left-hand panel corresponds to the first major variable region of the extracellular viral envelope, amino acids 137-155 in Figure 2. The right-hand 
panel corresponds to the largest conserved region, which, in addition, possesses structural and hydrophilic&y properties suggestive of antigenicity. 
This region corresponds to amino acids 473-518 immediately 5’to the envelope processing site shown in Figure 2. Ovals denote hydrophilic regions 
and diamonds hydrophobic regions. The radius of an oval or a diamond over a residue is proportional to the mean hydrophilicity or hydrophobicity 
as calculated for that residue plus the next four residues. Positions of 5 turns are indicated by turns of the chain (Z), a helices as bold coils(m), 
f3 sheets as narrow zigzags (* ), and random coils as wide zigzags (-). 
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&ding cattle, swine, sheep, goats, buffalo, and antelope 
(Weddell et al., 1985). A selection process for envelope 
variation related to cell membrane characteristics within 
and between species is also of special relevance to HTLV- 
IlllLAV research, as are mechanisms involving genetic 
recombination, since a novel simian retrovirus (STLV-III, 
for Simian T-Lymphotropic Virus Type Ill) recently isolated 
from four diseased rhesus macaques (three with im-,, 
munodeficiency and one with transmitted lymphoma) has 
been found to be very similar to HTLV-IIIILAV in its mor- 
phology, protein structure, and immunologic characteris- 
tics (Kanki et al., 1985; Daniel et al., 1985). Antibodies to 
this virus (or a close relative) were identified in 28 of 87 
healthy African green monkeys from central Africa (caught 
in the wild), as well as in a number of clinically asymptom- 
atic West African prostitutes (Barin et al., 1985b). The fact 
that this retrovirus has infected two species of Old World 
primates, and possibly man, and the fact that it is highly 
related to HTLV-IIIILAV suggests that the evolutionary ori- 
gins of STLV-III and HTLV-IIIILAV are similar. That their 
envelope proteins are less related than their gag proteins 
underscores the potential importance of variation in the 
envelope gene of HTLV-IIIILAV as a determinant of bio- 
logic activity. 
Whether or not the observed propensity for variation in 
HTLV-IIIILAV has biologic significance has yet to be for- 
mally proven. However, such extensive variation in the 
different genes of this virus clearly has the potential for 
drastically altering both its immunologic and biologic 
properties. These include the antigenicity and tissue tro- 
pism conferred by env; the polymerase, protease, and 
integrase functions of PO/; the gene regulatory properties 
of LTR and tat; and other potentially important products of 
sor and 3’ orf whose functions are still unknown. Future 
efforts to understand viral pathogenesis and to develop ef- 
fective preventive and treatment measures for AIDS will 
have to take into account the extensive genomic heteroge- 
neity present in HTLV-IIIILAV. 
Experimental Procedures 
Virus isolation 
Virus was isolated from patients’ peripheral blood mononuclear ceils, 
transmitted to immortalized T ceil lines, and propagated in tissue cul- 
ture as described (Popovic et al., 1984; Hahn et al., 1988). 
Molecular Cloning of HAT-3 and WMJ-1 
Lambda (k) phage libraries were constructed according to standard 
procedures (Maniatis et al., 1982) using the cloning vector Xgt WeebB 
and Ssti digested virat/celiular DNA which had been enriched by su- 
crose gradient centrifugation for 8-10 kb fragments. Both HTLV-illnr 
and HTLV-iiiwu~t DNA contained a single 9 kb Sstl fragment detect- 
able by Southern hybridization which corresponds to almost the entire 
HTLV-IIIILAV provirus in nonpermuted form. Phage plaques (approxi- 
mately 5 x 105) were screened with the HTLV-IIIILAV-specific 9 kb 
Sstl viral insert from 5BH-10 (Hahn et al., 1984) that had been sub- 
cloned into SP84. Positive signals were plaque-purified and character- 
ized. For nucieotide sequencing, the 9 kb inserts from both HAT3 (a 
clone from isolate HTLV-Illnr) and WMJ-1 (a clone from isolate HTLV- 
iiiWuJ;() were self-ligated, cut with Psti, and subcloned into the Psti 
site of either pBR322 or SP84. Sequencing reactions were then per- 
formed using these subgenomic clones. Detailed restriction cleavage 
patterns of both HAT-3 and WMJ-1 corresponded exactly (25 out of 25 
restriction sites) to the predominant proviral forms present in the 
respective ceil lines. 
Nucleotlds Sequence Analysis 
Nucieotide sequencing was performed according to Maxam and Gil- 
bert (1980). Plasmid subclones were cleaved with the appropriate re- 
striction enzymes and end-labeled using poiynucleotide kinase and 
FP-ATP for 5’ ends, and c 32P-dNTP plus DNA polymerase (Kienow 
fragment) or c =P-ddATP plus terminal deoxyrtbonucleotidyl transfer- 
ase for 3’ ends. Labeled fragments were cleaved with a second en- 
zyme, separated by polyacrylamide gel eiectrophoresis, and eluted 
into buffer. In some instances, double-labeled fragments were pm- 
pared, strand-separated, and sequenced individually. The sequences 
of both envelope genes and most of the remainder of 5HAT-3 was con- 
firmed by sequence analysis of both DNA strands. The computer pro- 
gram of Queen and Korn (1980) was used for translating the nucleotide 
sequences into amino acids. Nucieotide and amino acid sequences 
were aligned pairwise using NUCALN and PRTALN (Wilbur and Lip- 
man, 1983). 
Computer-As&ted Analysis of Envelops Variation 
A computer program was written that compared the aligned amino acid 
sequencesof BH-10, ARV-2, LABIA, WMJ-1, and HAT-3 and plotted rel- 
ative variation, or divergence, as a function of amino acid position 
within the envelope. For this analysis, the aligned amino acid se- 
quences shown in Figure 2 were analyzed column by column. Column 
scores were computed based on the number of mismatched pairs with 
values ranging from 0 (no mismatches, complete homology) tc 10 (all 
mismatches, no homology). The absence of an amino acid (deletion) 
at any position was considered to be a mismatch. Each column score 
was averaged over twc column scores on each side resulting in a win- 
dow size of five. This mean value for each amino acid position was 
plotted from 0 to 10 above the corresponding envelope amino acid po- 
sition shown on the abscissa. 
Secondary Structure Analysis 
A computer program that predicts secondary structures of proteins ac- 
cording to the rules of Chou and Fasman (1974) and superimposes 
values for hydrophiiicity according to Hopp and Woods (1981) was em- 
ployed to analyze the envelope amino acid sequences of the five differ- 
ent AIDS virus clones. This program, originally designed by E. Golub 
(Cohen et al., 1984) was modified slightly and adapted to the VAX750 
computer (S. Modrow, unpublished data). The probability of the occur- 
rence of a helices, 8 pleated sheets, random coils, and 5 turn regions 
were evaluated using stringent conditions: p boundary 21, with p8 >pa 
and pt > pa (p8 = probability for 8 turn region). The parameters for 
hydrophiiicity were averaged over five amino acid residues with a limit 
of 0.7. 8 turns adjacent to 8 sheets or a helical regions in a non- 
hydrophobic environment are likely candidates for antigenic sites 
since they frequently form loop-like structures on the outside of the pro- 
tein surface (Westhoff et al., 1984). 
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